12 Health Care Stocks Moving In Monday's Intraday Session
I'm LongbridgeAI, I can summarize articles.During Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Silence Therapeutics (up 125.6%), SCWorx (up 80.32%), and Disc Medicine (up 40.01%). Conversely, major losers featured EyePoint Pharmaceuticals (down 85.7%) and Matinas BioPharma (down 33.34%). These sharp movements followed recent Q4 earnings reports released four days prior.
Gainers
- Silence Therapeutics (NASDAQ:SLN) stock increased by 125.6% to $19.59 during Monday's regular session. The market value of their outstanding shares is at $581.1 million.
- SCWorx (NASDAQ:WORX) stock increased by 80.32% to $2.49.
- Disc Medicine (NASDAQ:IRON) shares moved upwards by 40.01% to $79.58. The market value of their outstanding shares is at $2.1 billion.
- CytoSorbents (NASDAQ:CTSO) shares increased by 20.18% to $4.94. The company's market cap stands at $9.6 million.
- Actinium Pharmaceuticals (AMEX:ATNM) stock increased by 19.05% to $1.35. The market value of their outstanding shares is at $33.2 million.
- Advanced Biomed (NASDAQ:ADVB) stock increased by 18.34% to $4.71. The market value of their outstanding shares is at $7.9 million. As per the news, the Q4 earnings report came out 4 days ago.
Losers
- EyePoint (NASDAQ:EYPT) shares decreased by 85.7% to $0.43 during Monday's regular session. The company's market cap stands at $270.7 million.
- Matinas BioPharma Hldgs (AMEX:MTNB) stock decreased by 33.34% to $1.58. The company's market cap stands at $35.5 million.
- Estrella Immunopharma (NASDAQ:ESLA) stock fell 29.88% to $0.3. The market value of their outstanding shares is at $23.2 million.
- Lunai Bioworks (NASDAQ:LNAI) shares declined by 26.67% to $0.5. The company's market cap stands at $3.7 million. As per the press release, Q4 earnings came out 4 days ago.
- CDT Equity (NASDAQ:CDT) stock declined by 26.16% to $0.17.
- NeuroSense Therapeutics (NASDAQ:NRSN) shares declined by 22.64% to $2.38. The market value of their outstanding shares is at $6.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock978characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.